{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:31:14Z","timestamp":1794853874318,"version":"4.9.1"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Several ocular biomarkers have been proposed for the early detection of Alzheimer disease (AD) and mild cognitive impairment (MCI), particularly fundus photography, optical coherence tomography (OCT), and OCT angiography (OCTA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To perform an umbrella review of systematic reviews to assess the diagnostic accuracy of ocular biomarkers for early diagnosis of Alzheimer disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Sources<\/jats:title><jats:p>MEDLINE, Embase, and PsycINFO were searched from January 2000 to November 2021. The references of included reviews were also searched.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Selection<\/jats:title><jats:p>Systematic reviews investigating the diagnostic accuracy of ocular biomarkers to detect AD and MCI, in secondary care or memory clinics, against established clinical criteria or clinical judgment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Extraction and Synthesis<\/jats:title><jats:p>The Preferred Reporting Items for Systematic Reviews and Meta-analyses (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.equator-network.org\/reporting-guidelines\/prisma\/\">PRISMA<\/jats:ext-link>) reporting guideline checklist was followed and the Risk Of Bias in Systematic reviews tool was used to assess review quality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The prespecified outcome was the accuracy of ocular biomarkers for diagnosing AD and MCI. The area under the curve (AUC) was derived from standardized mean difference.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From the 591 titles, 14 systematic reviews were included (median [range] number of studies in each review, 14 [5-126]). Only 4 reviews were at low risk of bias on all Risk of Bias in Systematic Reviews domains. The imaging-derived parameters with the most evidence for detecting AD compared with healthy controls were OCT peripapillary retinal nerve fiber layer thickness (38 studies including 1883 patients with AD and 2510 controls; AUC\u2009=\u20090.70; 95% CI, 0.53-0.79); OCTA foveal avascular zone (5 studies including 177 patients with AD and 371 controls; AUC\u2009=\u20090.73; 95% CI, 0.50-0.89); and saccadic eye movements prosaccade latency (30 studies including 651 patients with AD\/MCI and 771 controls; AUC\u2009=\u20090.64; 95% CI, 0.58-0.69). Antisaccade error was investigated in fewer studies (12 studies including 424 patients with AD\/MCI and 382 controls) and yielded the best accuracy (AUC\u2009=\u20090.79; 95% CI, 0.70-0.88).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This umbrella review has highlighted limitations in design and reporting of the existing research on ocular biomarkers for diagnosing AD. Parameters with the best evidence showed poor to moderate diagnostic accuracy in cross-sectional studies. Future longitudinal studies should investigate whether changes in OCT and OCTA measurements over time can yield accurate predictions of AD onset.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2022.4845","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:01:45Z","timestamp":1668700905000},"page":"84","source":"Crossref","is-referenced-by-count":63,"title":["Ocular Biomarkers for Alzheimer Disease Dementia"],"prefix":"10.1001","volume":"141","author":[{"given":"Eliana","family":"Costanzo","sequence":"first","affiliation":[{"name":"IRCCS-Fondazione Bietti, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Lengyel","sequence":"additional","affiliation":[{"name":"Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Parravano","sequence":"additional","affiliation":[{"name":"IRCCS-Fondazione Bietti, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Biagini","sequence":"additional","affiliation":[{"name":"Department NEUROFARBA, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Veldsman","sequence":"additional","affiliation":[{"name":"Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmanPreet","family":"Badhwar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Montreal, Montreal, Qu\u00e9bec, Canada"},{"name":"Centre de recherche de l'Institut Universitaire de Geriatrie, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Betts","sequence":"additional","affiliation":[{"name":"Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"},{"name":"German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany"},{"name":"Center for Behavioral Brain Sciences, University of Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cherubini","sequence":"additional","affiliation":[{"name":"Geriatria, Accettazione geriatrica e Centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Llewellyn","sequence":"additional","affiliation":[{"name":"College of Medicine and Health, University of Exeter, Exeter, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilianna","family":"Lourida","sequence":"additional","affiliation":[{"name":"College of Medicine and Health, University of Exeter, Exeter, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"MacGillivray","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Rittman","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin You","family":"Tai","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Virgili","sequence":"additional","affiliation":[{"name":"Department NEUROFARBA, University of Florence, Florence, Italy"},{"name":"Centre for Public Health, Queens University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10248","key":"erv220002r1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"erv220002r2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7040097","article-title":"Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research.","volume":"7","author":"Yiannopoulou","year":"2019","journal-title":"Biomedicines"},{"key":"erv220002r3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer\u2019s disease.","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"erv220002r4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/alz.v16.1","article-title":"Developing retinal biomarkers for the earliest stages of Alzheimer's disease: what we know, what we don't, and how to move forward.","volume":"16","author":"Alber","year":"2020","journal-title":"Alzheimers Dement"},{"key":"erv220002r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/EB.S235238","article-title":"Optical coherence tomography in patients with Alzheimer\u2019s disease: what can it tell us?","volume":"13","author":"Song","year":"2021","journal-title":"Eye Brain"},{"key":"erv220002r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101361","article-title":"Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.","volume":"69","author":"Ge","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"3","key":"erv220002r7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/mdc3.v9.3","article-title":"Eye movement disorders in movement disorders.","volume":"9","author":"Kassavetis","year":"2022","journal-title":"Mov Disord Clin Pract"},{"issue":"6","key":"erv220002r8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/ICU.0000000000000807","article-title":"Ophthalmic manifestations of dementing disorders.","volume":"32","author":"Douglas","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"issue":"8","key":"erv220002r9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/aos.13472","article-title":"Can the retina be used to diagnose and plot the progression of Alzheimer\u2019s disease?","volume":"95","author":"Mahajan","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"erv220002r10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","article-title":"Spectral-domain OCT measurements in Alzheimer's disease: a systematic review and meta-analysis.","volume":"126","author":"Chan","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"erv220002r11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/08820538.2017.1332233","article-title":"Retinal findings on OCT in systemic conditions.","volume":"33","author":"Chhablani","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"erv220002r12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","article-title":"Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"6","author":"den Haan","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"erv220002r13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.dadm.2016.07.004","article-title":"Retinal nerve fiber layer thickness in amnestic mild cognitive impairment: case-control study and meta-analysis.","volume":"4","author":"Knoll","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"10","key":"erv220002r14","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56100553","article-title":"Ganglion cell layer thinning in Alzheimer\u2019s disease.","volume":"56","author":"L\u00f3pez-de-Eguileta","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"erv220002r15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.578698","article-title":"Optical coherence tomography in mild cognitive impairment: a systematic review and meta-analysis.","volume":"11","author":"Mejia-Vergara","year":"2020","journal-title":"Front Neurol"},{"key":"erv220002r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106036","article-title":"Optical coherence tomography in mild cognitive impairment: systematic review and meta-analysis.","volume":"196","author":"Noah","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"erv220002r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255362","article-title":"Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer\u2019s disease patients: a meta-analysis.","volume":"16","author":"Hui","year":"2021","journal-title":"PLoS One"},{"key":"erv220002r18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.683824","article-title":"A systematic review and meta-analysis of retinal microvascular features in Alzheimer\u2019s disease.","volume":"13","author":"Jin","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"erv220002r19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41433-021-01648-1","article-title":"Optical coherence tomography angiography in Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"36","author":"Katsimpris","year":"2021","journal-title":"Eye (Lond)"},{"issue":"1","key":"erv220002r20","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.v13.1","article-title":"The application of optical coherence tomography angiography in Alzheimer\u2019s disease: a systematic review.","volume":"13","author":"Rifai","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"erv220002r21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3389\/fneur.2020.01009","article-title":"The application of optical coherence tomography angiography in cerebral small vessel disease, ischemic stroke, and dementia: a systematic review.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Neurol"},{"key":"erv220002r22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnins.2020.00016","article-title":"Systematic review on fractal dimension of the retinal vasculature in neurodegeneration and stroke: assessment of a potential biomarker.","volume":"14","author":"Lemmens","year":"2020","journal-title":"Front Neurosci"},{"key":"erv220002r23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.dadm.2016.11.001","article-title":"The application of retinal fundus camera imaging in dementia: a systematic review.","volume":"6","author":"McGrory","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"erv220002r24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3988\/jcn.2020.16.1.19","article-title":"Association between retinal vascular geometric changes and cognitive impairment: a systematic review and meta-analysis.","volume":"16","author":"Wu","year":"2020","journal-title":"J Clin Neurol"},{"key":"erv220002r25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.dadm.2016.09.001","article-title":"Nonvascular retinal imaging markers of preclinical Alzheimer\u2019s disease.","volume":"4","author":"Snyder","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"erv220002r26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11739-012-0846-1","article-title":"Multiple systematic reviews: methods for assessing discordances of results.","volume":"7","author":"Moja","year":"2012","journal-title":"Intern Emerg Med"},{"issue":"3","key":"erv220002r27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jclinepi.2014.11.004","article-title":"Discordances originated by multiple meta-analyses on interventions for myocardial infarction: a systematic review.","volume":"68","author":"Lucenteforte","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"erv220002r28","doi-asserted-by":"publisher","first-page":"f4501","DOI":"10.1136\/bmj.f4501","article-title":"Overlapping meta-analyses on the same topic: survey of published studies.","volume":"347","author":"Siontis","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"erv220002r29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040078","article-title":"Epidemiology and reporting characteristics of systematic reviews.","volume":"4","author":"Moher","year":"2007","journal-title":"PLoS Med"},{"issue":"9","key":"erv220002r30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"erv220002r31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: A new tool to assess risk of bias in systematic reviews was developed.","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"erv220002r32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5093\/ejpalc2018a5","article-title":"Transforming the area under the normal curve (AUC) into Cohen\u2019s d, Pearson\u2019s r pb, odds-ratio, and natural log odds-ratio: two conversion tables.","volume":"10","author":"Salgado","year":"2018","journal-title":"Eur J Psychol Appl Legal Context"},{"issue":"9","key":"erv220002r33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment.","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"key":"erv220002r34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajo.2016.06.038","article-title":"Retinal neurodegeneration associated with peripheral nerve conduction and autonomic nerve function in diabetic patients.","volume":"170","author":"Kim","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"erv220002r35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.dadm.2015.03.001","article-title":"A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography.","volume":"1","author":"Thomson","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"issue":"8","key":"erv220002r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134750","article-title":"Optical coherence tomography in Alzheimer\u2019s disease: a meta-analysis.","volume":"10","author":"Coppola","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"erv220002r37","first-page":"263","article-title":"Meta-analysis of the relationship of peripheral retinal nerve fiber layer thickness to Alzheimer\u2019s disease and mild cognitive impairment.","volume":"27","author":"Wang","year":"2015","journal-title":"Shanghai Arch Psychiatry"},{"issue":"10","key":"erv220002r38","first-page":"566","article-title":"Optical coherence tomography (OCT) a new diagnostic tool in psychiatry?","volume":"82","author":"Sch\u00f6nfeldt-Lecuona","year":"2014","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"8","key":"erv220002r39","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1136\/bjo.2008.141994","article-title":"Retinal microvascular abnormalities and cognitive dysfunction: a systematic review.","volume":"92","author":"Ding","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"erv220002r40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/jcbfm.2013.58","article-title":"Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review.","volume":"33","author":"Heringa","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"erv220002r41","first-page":"401","article-title":"Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer\u2019s disease: a meta-analysis.","volume":"5","author":"He","year":"2012","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"erv220002r42","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JAD-210250","article-title":"Visual impairment, eye diseases, and dementia risk: a systematic review and meta-analysis.","volume":"83","author":"Kuzma","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"erv220002r43","first-page":"987","article-title":"Meta-analysis of transcriptomic changes in optic nerve injury and neurodegenerative models reveals a fundamental response to injury throughout the central nervous system.","volume":"23","author":"Donahue","year":"2017","journal-title":"Mol Vis"},{"issue":"8","key":"erv220002r44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00347-019-0883-5","article-title":"Optical coherence tomography angiography in neuronal diseases: preliminary findings.","volume":"116","author":"Mardin","year":"2019","journal-title":"Ophthalmologe"},{"key":"erv220002r45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eurpsy.2019.09.006","article-title":"Electroretinography in psychiatry: a systematic literature review.","volume":"62","author":"Youssef","year":"2019","journal-title":"Eur Psychiatry"},{"key":"erv220002r46","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.572337","article-title":"Afferent and efferent visual markers of Alzheimer\u2019s disease: a review and update in early stage disease.","volume":"12","author":"Wu","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"erv220002r47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eurpsy.2019.09.006","article-title":"Saccadic eye movement in mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"32","author":"Opwonya","year":"2022","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"erv220002r48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11065-017-9362-4","article-title":"Prosaccade and antisaccade paradigms in persons with Alzheimer's disease: a meta-analytic review.","volume":"28","author":"Kahana Levy","year":"2018","journal-title":"Neuropsychol Rev"},{"issue":"1","key":"erv220002r49","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1038\/s41467-019-12242-1","article-title":"Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease.","volume":"10","author":"Hadoux","year":"2019","journal-title":"Nat Commun"},{"issue":"11","key":"erv220002r50","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1021\/acschemneuro.9b00331","article-title":"In vivo assessment of retinal biomarkers by hyperspectral imaging: early detection of Alzheimer's disease.","volume":"10","author":"More","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"erv220002r51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12874-016-0252-x","article-title":"Defining the clinical pathway in cochrane diagnostic test accuracy reviews.","volume":"16","author":"Gopalakrishna","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"erv220002r52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajo.2017.11.011","article-title":"Reproducibility of vessel density, fractal dimension, and foveal avascular zone using 7 different optical coherence tomography angiography devices.","volume":"186","author":"Corvi","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"erv220002r53","first-page":"2036","article-title":"Enhancing the accuracy of glaucoma detection from OCT probability maps using convolutional neural networks.","volume":"2019","author":"Thakoor","year":"2019","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"8","key":"erv220002r54","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamaophthalmol.2022.2099","article-title":"Association of optical coherence tomography and optical coherence tomography angiography retinal features with visual function in older adults.","volume":"140","author":"Dong","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"erv220002r55","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamaophthalmol.2022.2100","article-title":"Promises and pitfalls of retinal biomarkers in systemic health and disease.","volume":"140","author":"Kashani","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"erv220002r56","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s11606-008-0583-3","article-title":"The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination.","volume":"23","author":"Simel","year":"2008","journal-title":"J Gen Intern Med"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2798773\/jamaophthalmology_costanzo_2022_rv_220002_1673287562.48179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T16:27:49Z","timestamp":1674145669000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2798773"}},"subtitle":["An Umbrella Review of Systematic Reviews and Meta-analyses"],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.4845","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}